Resultats de la cerca - Lièvre, Astrid

Patient healthcare trajectories of intrahepatic cholangiocarcinoma in France: A nationwide retrospective analysis per Neuzillet, Cindy, Emery, Corinne, Teissier, Clément, Bouée, Stéphane, Lièvre, Astrid

Obtenir text complet Obtenir text complet Obtenir text complet

Brain metastases from pancreatic adenocarcinoma per Zaanan, Aziz, Lequoy, Marie, Landi, Bruno, Lievre, Astrid, Franco, Dominique, Taïeb, Julien

Obtenir text complet Obtenir text complet Obtenir text complet

Significant decrease in interval colorectal cancer incidence after implementing immunochemical testing in a multiple-round guaiac-based screening programme per Bretagne, Jean-François, Carlo, Aurore, Piette, Christine, Rousseau, Chloé, Cosson, Mathilde, Lièvre, Astrid

Obtenir text complet Obtenir text complet Obtenir text complet

Is the gene encoding Chibby implicated as a tumour suppressor in colorectal cancer ? per Gad, Sophie, Teboul, David, Lièvre, Astrid, Goasguen, Nicolas, Berger, Anne, Beaune, Philippe, Laurent-Puig, Pierre

Obtenir text complet Obtenir text complet Obtenir text complet

Incidental colorectal focal (18) F-FDG uptake: a novel indication for colonoscopy per Rigault, Eugénie, Lenoir, Laurence, Bouguen, Guillaume, Pagenault, Mael, Lièvre, Astrid, Garin, Etienne, Siproudhis, Laurent, Bretagne, Jean-François

Obtenir text complet Obtenir text complet Obtenir text complet

Prognostic value of serum CYFRA 21-1 1 in patients with anal canal squamous cell carcinoma treated with radio(chemo)therapy per Gauthé, Mathieu, Richard-Molard, Marion, Rigault, Eugénie, Buecher, Bruno, Mariani, Pascale, Bellet, Dominique, Cacheux, Wulfran, Lièvre, Astrid

Obtenir text complet Obtenir text complet Obtenir text complet

Multidisciplinary team meetings: are all patients presented and does it impact quality of care and survival – a registry-based study per Rollet, Quentin, Bouvier, Véronique, Moutel, Grégoire, Launay, Ludivine, Bignon, Anne-Laure, Bouhier-Leporrier, Karine, Launoy, Guy, Lièvre, Astrid

Obtenir text complet Obtenir text complet Obtenir text complet

Bevacizumab plus FOLFIRI or FOLFOX in chemotherapy-refractory patients with metastatic colorectal cancer: a retrospective study per Lièvre, Astrid, Samalin, Emmanuelle, Mitry, Emmanuel, Assenat, Eric, Boyer-Gestin, Christine, Lepère, Céline, Bachet, Jean-Baptiste, Portales, Fabienne, Vaillant, Jean-Nicolas, Ychou, Marc, Rougier, Philippe

Obtenir text complet Obtenir text complet Obtenir text complet

FOLFIRINOX De‐Escalation in Advanced Pancreatic Cancer: A Multicenter Real‐Life Study per Chevalier, Hortense, Vienot, Angélique, Lièvre, Astrid, Edeline, Julien, El Hajbi, Farid, Peugniez, Charlotte, Vernerey, Dewi, Meurisse, Aurélia, Hammel, Pascal, Neuzillet, Cindy, Borg, Christophe, Turpin, Anthony

Obtenir text complet Obtenir text complet Obtenir text complet

Incidental anal (18)fluorodeoxyglucose uptake: Should we further examine the patient? per Moussaddaq, Anne-Sophie, Brochard, Charlène, Palard-Novello, Xavier, Garin, Etienne, Wallenhorst, Timothée, Le Balc’h, Eric, Merlini L’heritier, Alexandre, Grainville, Thomas, Siproudhis, Laurent, Lièvre, Astrid

Obtenir text complet Obtenir text complet Obtenir text complet

Management of digestive cancers during the COVID-19 second wave: A French intergroup point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFR) per Tougeron, David, Michel, Pierre, Lièvre, Astrid, Ducreux, Michel, Gaujoux, Sébastien, Guiu, Boris, Huguet, Florence, Lecomte, Thierry, Lepage, Côme, Louvet, Christophe, Maggiori, Léon, Mariani, Pascale, Aparicio, Thomas, Bouché, Olivier

Obtenir text complet Obtenir text complet Obtenir text complet

Protein biomarkers predictive for response to anti-EGFR treatment in RAS wild-type metastatic colorectal carcinoma per Lièvre, Astrid, Ouine, Bérèngere, Canet, Jim, Cartier, Aurélie, Amar, Yael, Cacheux, Wulfran, Mariani, Odette, Guimbaud, Rosine, Selves, Janick, Lecomte, Thierry, Guyetant, Serge, Bieche, Ivan, Berger, Frédérique, de Koning, Leanne

Obtenir text complet Obtenir text complet Obtenir text complet

Correction: Protein biomarkers predictive for response to anti-EGFR treatment in RAS wild-type metastatic colorectal carcinoma per Lièvre, Astrid, Ouine, Bérèngere, Canet, Jim, Cartier, Aurélie, Amar, Yael, Cacheux, Wulfran, Mariani, Odette, Guimbaud, Rosine, Selves, Janick, Lecomte, Thierry, Guyetant, Serge, Bieche, Ivan, Berger, Frédérique, de Koning, Leanne

Obtenir text complet Obtenir text complet Obtenir text complet

FOLFIRINOX relative dose intensity and disease control in advanced pancreatic adenocarcinoma per Vary, Antonin, Lebellec, Loïc, Di Fiore, Frédéric, Penel, Nicolas, Cheymol, Claire, Rad, Emilia, El Hajbi, Farid, Lièvre, Astrid, Edeline, Julien, Bimbai, André Michel, Le Deley, Marie-Cécile, Turpin, Anthony

Obtenir text complet Obtenir text complet Obtenir text complet

Genetic polymorphisms of MMP1, MMP3 and MMP7 gene promoter and risk of colorectal adenoma per Lièvre, Astrid, Milet, Jacqueline, Carayol, Jérôme, Le Corre, Delphine, Milan, Chantal, Pariente, Alexandre, Nalet, Bernard, Lafon, Jacques, Faivre, Jean, Bonithon-Kopp, Claire, Olschwang, Sylviane, Bonaiti-Pellié, Catherine, Laurent-Puig, Pierre

Obtenir text complet Obtenir text complet Obtenir text complet

Correction to: Gemcitabine + Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO study per Zaibet, Sonia, Hautefeuille, Vincent, Auclin, Edouard, Lièvre, Astrid, Tougeron, David, Sarabi, Mathieu, Gilabert, Marine, Wasselin, Julie, Edeline, Julien, Artru, Pascal, Bechade, Dominique, Morin, Clémence, Ducoulombier, Agnes, Taieb, Julien, Pernot, Simon

Obtenir text complet Obtenir text complet Obtenir text complet

Gemcitabine + Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO study per Zaibet, Sonia, Hautefeuille, Vincent, Auclin, Edouard, Lièvre, Astrid, Tougeron, David, Sarabi, Mathieu, Gilabert, Marine, Wasselin, Julie, Edeline, Julien, Artru, Pascal, Bechade, Dominique, Morin, Clémence, Ducoulombier, Agnes, Taieb, Julien, Pernot, Simon

Obtenir text complet Obtenir text complet Obtenir text complet

Prognostic factors of BRAF V600E colorectal cancer with liver metastases: a retrospective multicentric study per Javed, Sahir, Benoist, Stéphane, Devos, Patrick, Truant, Stéphanie, Guimbaud, Rosine, Lièvre, Astrid, Sefrioui, David, Cohen, Romain, Artru, Pascal, Dupré, Aurélien, Bachet, Jean-Baptiste, de la Fouchardière, Christelle, Ploquin, Anne, Turpin, Anthony

Obtenir text complet Obtenir text complet Obtenir text complet

COVID-19 epidemic: Proposed alternatives in the management of digestive cancers: A French intergroup clinical point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR) per Di Fiore, Frederic, Bouché, Olivier, Lepage, Come, Sefrioui, David, Gangloff, Alice, Schwarz, Lilian, Tuech, Jean Jacques, Aparicio, Thomas, Lecomte, Thierry, Boulagnon-Rombi, Camille, Lièvre, Astrid, Manfredi, Sylvain, Phelip, Jean Marc, Michel, Pierre

Obtenir text complet Obtenir text complet Obtenir text complet

Radioembolization Plus Chemotherapy for First-line Treatment of Locally Advanced Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial per Edeline, Julien, Touchefeu, Yann, Guiu, Boris, Farge, Olivier, Tougeron, David, Baumgaertner, Isabelle, Ayav, Ahmet, Campillo-Gimenez, Boris, Beuzit, Luc, Pracht, Marc, Lièvre, Astrid, Le Sourd, Samuel, Boudjema, Karim, Rolland, Yan, Boucher, Eveline, Garin, Etienne

Obtenir text complet Obtenir text complet Obtenir text complet